KAYAK (NASDAQ:KYAK): According to JPMorgan, KAYAK probably won’t duplicate the recent weak results of other names in the online travel and online travel ad space, since the firm believes that the company has little European exposure and does not have to deal with the “over-monetization issues” which have hurt other travel ad players. The firm keeps a Buy rating and a $35 target on the stock.
Qihoo 360 Technology Co Ltd’s (NYSE:QIHU) new search product has begun to gain popularity and should monetize by 2012, states Jefferies. The firm predicts that the Q3 ad outlook will be strong and that web games growth will also be strong because of paying user base expansion. Shares have a Buy rating.
Aspen Technology Inc. (NASDAQ:AZPN) reported Q4 results that William Blair sees as solid, the firm believes that Aspen possesses a dominant market position and is positioned to keep outperforming the broader technology group throughout the next 12 months. The firm keeps an Outperform rating on the stock.
Acorda Therapeutics, Inc. (NASDAQ:ACOR): Leerink thinks that the potential from Phase II Ampyra post stroke deficit data that is expected during the first half of next year is not currently reflected in Acorda Therapeutics’ valuation. The firm recommends buying shares at the current level and keeps an Outperform rating on the stock.
Williams-Sonoma Inc. (NYSE:WSM): Jefferies views Williams-Sonoma’s reported results as very good. The firm believes that the company is a long-term growth story with tremendous upside, and it keeps a Buy rating on the stock.
Don’t Miss: Another Major Investor DUMPS Facebook.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.